JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

JNJ

186.79

+0.34%↑

ABT

125.77

+1.66%↑

TMO

565.15

+0.26%↑

ISRG

538.71

-0.99%↓

DHR

213.79

-0.14%↓

Kodu・Aktsiate loetelu・Retractable Technologies Inc

Retractable Technologies Inc

Suletud

SektorTervishoid

0.82 -3.53

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.82

Max

0.86

Põhinäitajad
By Trading Economics
Sissetulek	10M -87K
Müük	2.2M 10M
Aktsiakasum	-0.005
Kasumimarginaal	-0.837
Töötajad	221
EBITDA	10M 1.8M

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	12. nov 2025

Turustatistika
By TradingEconomics
Turukapital	1.9M 26M
Eelmine avamishind	4.35
Eelmine sulgemishind	0.82

Uudiste sentiment

By Acuity

29%

71%

69 / 373 Pingereas Healthcare

Retractable Technologies Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. nov 2025, 23:57 UTC

Tulu

Naver's Third-Quarter Earnings Rose on AI Push

4. nov 2025, 23:10 UTC

Omandamised, ülevõtmised, äriostud

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

4. nov 2025, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. nov 2025, 23:48 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

4. nov 2025, 23:37 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

4. nov 2025, 23:30 UTC

Tulu

Itau Unibanco 3Q Net BRL33.7B >ITUB

4. nov 2025, 23:25 UTC

Tulu

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

4. nov 2025, 23:25 UTC

Tulu

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

4. nov 2025, 23:24 UTC

Tulu

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

4. nov 2025, 23:23 UTC

Tulu

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

4. nov 2025, 23:06 UTC

Tulu

Review & Preview: Tech Check -- Barrons.com

4. nov 2025, 22:52 UTC

Tulu

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

4. nov 2025, 22:33 UTC

Tulu

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

4. nov 2025, 22:29 UTC

Tulu

Ashland 4Q Adj EPS $1.08 >ASH

4. nov 2025, 22:29 UTC

Tulu

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

4. nov 2025, 22:28 UTC

Tulu

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

4. nov 2025, 22:27 UTC

Tulu

Ashland 4Q Cont Ops EPS 73c >ASH

4. nov 2025, 22:27 UTC

Tulu

Ashland 4Q EPS 71c >ASH

4. nov 2025, 22:27 UTC

Tulu

Ashland 4Q Sales $478M >ASH

4. nov 2025, 22:23 UTC

Tulu

Ovintiv 3Q EPS 57c >OVV

4. nov 2025, 22:19 UTC

Market Talk

Canada Budget: Snap Election Talk Might Cool -- Market Talk

4. nov 2025, 22:16 UTC

Tulu

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

4. nov 2025, 22:14 UTC

Omandamised, ülevõtmised, äriostud

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

4. nov 2025, 22:13 UTC

Omandamised, ülevõtmised, äriostud

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

4. nov 2025, 22:13 UTC

Omandamised, ülevõtmised, äriostud

Consortium: Able to Finance a Deal With Available Liquidity

4. nov 2025, 22:12 UTC

Omandamised, ülevõtmised, äriostud

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

4. nov 2025, 22:11 UTC

Tulu

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

4. nov 2025, 22:11 UTC

Omandamised, ülevõtmised, äriostud

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

4. nov 2025, 22:10 UTC

Omandamised, ülevõtmised, äriostud

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4. nov 2025, 22:07 UTC

Tulu

Kinross Gold Raises Dividend to $0.035 >K.T

Võrdlus sarnastega

Hinnamuutus

Retractable Technologies Inc Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

Osta

Hoia

Müü

Põhineb 0 analüütiku instrumendi Retractable Technologies Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

69 / 373 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Retractable Technologies Inc

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.